{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:05:12Z","timestamp":1787025912233,"version":"build-2736575974"},"reference-count":68,"publisher":"SAGE Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WOR"],"published-print":{"date-parts":[[2018,2,3]]},"DOI":"10.3233\/wor-172656","type":"journal-article","created":{"date-parts":[[2018,2,6]],"date-time":"2018-02-06T13:09:43Z","timestamp":1517922583000},"page":"165-172","source":"Crossref","is-referenced-by-count":10,"title":["Important exposure controls for protection against antineoplastic agents: Highlights for oncology health care workers"],"prefix":"10.1177","volume":"59","author":[{"given":"Maryam","family":"Alehashem","sequence":"first","affiliation":[{"name":"Tracheal Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shadi","family":"Baniasadi","sequence":"additional","affiliation":[{"name":"Tracheal Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/WOR-172656_ref1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.7314\/APJCP.2013.14.1.69","article-title":"Improving safety-related knowledge, attitude and practices of nurses handling cytotoxic anticancer drug: Pharmacists\u2019 Experience in a general hospital, Malaysia","volume":"14","author":"Keat","year":"2013","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.3233\/WOR-172656_ref2","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1080\/15459624.2014.916809","article-title":"Adherence to Safe Handling Guidelines by Health Care Workers Who Administer Antineoplastic Drugs","volume":"11","author":"Boiano","year":"2014","journal-title":"J Occup Environ Hyg"},{"key":"10.3233\/WOR-172656_ref3","doi-asserted-by":"crossref","first-page":"216","DOI":"10.4212\/cjhp.v69i3.1558","article-title":"Causes of Health Care Workers\u2019 Exposure to Antineoplastic Drugs: An Exploratory Study","volume":"69","author":"Hon","year":"2016","journal-title":"Can J Hosp Pharm"},{"key":"10.3233\/WOR-172656_ref4","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/10773525.2015.1123380","article-title":"Applicability of the comet assay in evaluation of DNA damage in healthcare providers\u2019 working with antineoplastic drugs: A systematic review and meta-analysis","volume":"22","author":"Sakhvidi","year":"2016","journal-title":"Int J Occup Environ Health"},{"key":"10.3233\/WOR-172656_ref5","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.clinthera.2014.01.016","article-title":"Administration of anticancer drugs: Exposure in hospital nurses","volume":"36","author":"Rioufol","year":"2014","journal-title":"Clin Ther"},{"key":"10.3233\/WOR-172656_ref6","doi-asserted-by":"crossref","first-page":"273","DOI":"10.5491\/SHAW.2011.2.3.273","article-title":"Occupational exposure to antineoplastic drugs: Identification of job categories potentially exposed throughout the hospital medication system","volume":"2","author":"Hon","year":"2011","journal-title":"Saf Health Work"},{"key":"10.3233\/WOR-172656_ref7","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3233\/WOR-2011-1198","article-title":"Lack of genotoxicity in medical oncology nurses handling antineoplastic drugs: Effect of work environment and protective equipment","volume":"39","author":"Gulten","year":"2011","journal-title":"Work"},{"key":"10.3233\/WOR-172656_ref8","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1177\/1078155213498630","article-title":"Occupational exposure to anti-cancer drugs: A review of effects of new technology","volume":"20","author":"Vyas","year":"2014","journal-title":"J Oncol Pharm Pract"},{"key":"10.3233\/WOR-172656_ref9","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/ecc.12249","article-title":"Preventing the contamination of hospital personnel by cytotoxic agents: Evaluation and training of the para-professional healthcare workers in oncology units","volume":"24","author":"Kieffer","year":"2015","journal-title":"Eur J Cancer Care (Engl)"},{"key":"10.3233\/WOR-172656_ref10","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1188\/16.ONF.43-03AP","article-title":"Factors Influencing Nurses\u2019 Use of Hazardous Drug Safe-Handling Precautions","volume":"43","author":"Callahan","year":"2016","journal-title":"Oncol Nurs Forum"},{"key":"10.3233\/WOR-172656_ref11","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1188\/14.CJON.497-500","article-title":"Improving compliance with personal protective equipment use through the model for improvement and staff champions","volume":"18","author":"Hennessy","year":"2014","journal-title":"Clin J Oncol Nurs"},{"key":"10.3233\/WOR-172656_ref12","doi-asserted-by":"crossref","first-page":"216","DOI":"10.4212\/cjhp.v69i3.1558","article-title":"Causes of health care workers\u2019 exposure to antineoplastic drugs: An exploratory study","volume":"69","author":"Hon","year":"2016","journal-title":"Can J Hosp Pharm"},{"key":"10.3233\/WOR-172656_ref13","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1097\/00043764-198812000-00020","article-title":"Acute occupational exposure to antineoplastic agents","volume":"30","author":"McDiarmid","year":"1988","journal-title":"J Occup Med"},{"key":"10.3233\/WOR-172656_ref14","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/00002820-199308000-00005","article-title":"Acute symptoms associated with antineoplastic drug handling among nurses","volume":"16","author":"Valanis","year":"1993","journal-title":"Cancer Nurs"},{"key":"10.3233\/WOR-172656_ref15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.mrrev.2016.05.001","article-title":"Occupational exposure to cytostatic\/antineoplastic drugs and cytogenetic damage measured using the lymphocyte cytokinesis-block micronucleus assay: A systematic review of the literature and meta-analysis","volume":"770","author":"Villarini","year":"2016","journal-title":"Mutat Res"},{"key":"10.3233\/WOR-172656_ref16","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00420-013-0862-0","article-title":"Multicenter study of environmental contamination with antineoplastic drugs in 33 Canadian hospitals","volume":"87","author":"Merger","year":"2014","journal-title":"Int Arch Occup Environ Health"},{"key":"10.3233\/WOR-172656_ref17","unstructured":"U.S. Department of Labor, Occupational Safety and Health Administration. Work practice guidelines for personnel dealing with cytotoxic (antineoplastic) drugs. OSHA Publication 1986;8-1.1."},{"key":"10.3233\/WOR-172656_ref18","unstructured":"NIOSH Alert: Preventing occupational exposure to antineoplastic and other hazardous drugs in health care settings. Cincinnati, OH: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, DHHS (NIOSH) Publication 2004;165."},{"key":"10.3233\/WOR-172656_ref19","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.2146\/ajhp050529","article-title":"ASHP guidelines on handling hazardous drugs","volume":"63","author":"American Society of Health-System Pharmacists","year":"2006","journal-title":"Am J Health Syst Pharm"},{"key":"10.3233\/WOR-172656_ref20","unstructured":"Oncology Nursing Society. Cancer Chemotherapy Guidelines, Modules I\u2013V. Pittsburgh, Pa: Oncology Nursing Society 1988."},{"key":"10.3233\/WOR-172656_ref21","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/JOM.0b013e3181f72b63","article-title":"Evaluation of antineoplastic drug exposure of health care workers at three university-based US cancer centers","volume":"52","author":"Connor","year":"2010","journal-title":"J Occup Environ Med"},{"key":"10.3233\/WOR-172656_ref22","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ejon.2010.01.025","article-title":"Knowledge, attitudes and beliefs of Cypriot nurses on the handling of antineoplastic agents","volume":"14","author":"Kyprianou","year":"2010","journal-title":"Eur J Oncol Nurs"},{"key":"10.3233\/WOR-172656_ref23","first-page":"1","article-title":"Measuring extent of surface contamination produced by the handling of antineoplastic drugs in low- to middle-income country oncology health care settings","author":"M\u00fcller-Ram\u00edrez","year":"2016","journal-title":"Arch Environ Occup Health"},{"key":"10.3233\/WOR-172656_ref24","first-page":"374","article-title":"Environmental and biological monitoring of platinum-containing drugs in two hospital pharmacies using positive air pressure isolators","volume":"57","author":"Kopp","year":"2013","journal-title":"Ann Occup Hyg"},{"key":"10.3233\/WOR-172656_ref25","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.4187\/respcare.03817","article-title":"Precautionary practices of respiratory therapists and other health-care practitioners who administer aerosolized medications","volume":"60","author":"Tsai","year":"2015","journal-title":"Respir Care"},{"key":"10.3233\/WOR-172656_ref26","first-page":"575","article-title":"Oncology pharmacy units: A safety policy for handling hazardous drugs and related waste in low- and middle-income African countries-Angolan experience","volume":"9","author":"da Concei\u00e7\u00e3o","year":"2015","journal-title":"Ecancermedicalscience"},{"key":"10.3233\/WOR-172656_ref27","doi-asserted-by":"crossref","unstructured":"Polovich M . Safe handling of hazardous drugs. Online Journal of Issues in Nursing 2004;9.3.5.","DOI":"10.3912\/OJIN.Vol9No03Man05"},{"issue":"Suppl 58","key":"10.3233\/WOR-172656_ref28","first-page":"P1104","article-title":"Exposure to chemotherapy drugs and adverse health effects in oncology ward of a pulmonary teaching hospital","volume":"44","author":"Baniasadi","year":"2014","journal-title":"European Respiratory Journal"},{"key":"10.3233\/WOR-172656_ref29","first-page":"1","article-title":"ISOPP standards of practice: Safe-handling of cytotoxics","volume":"13","author":"International Society of Oncology Pharmacy Practicioners Standards Committee","year":"2007","journal-title":"J Oncol Pharm Pract"},{"key":"10.3233\/WOR-172656_ref30","first-page":"237","article-title":"Occupational dermal exposure to cyclophosphamide in Dutch hospitals","volume":"48","author":"Fransman","year":"2004","journal-title":"Ann OccupHyg"},{"key":"10.3233\/WOR-172656_ref31","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1248\/yakushi.130.903","article-title":"Evaluation of environmental contaminations and occupational exposures involved in preparation of chemotherapeutic drugs","volume":"130","author":"Maeda","year":"2010","journal-title":"Yakugaku Zasshi"},{"key":"10.3233\/WOR-172656_ref32","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1136\/oem.59.9.608","article-title":"Occupational exposure to cytotoxic drugs in two UK oncology wards","volume":"59","author":"Ziegler","year":"2002","journal-title":"Occup Environ Med"},{"key":"10.3233\/WOR-172656_ref33","first-page":"603","article-title":"Exposure to antineoplastic drugs in two UK hospital pharmacy units","volume":"49","author":"Mason","year":"2005","journal-title":"Ann Occup Hyg"},{"key":"10.3233\/WOR-172656_ref34","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/chromsci\/48.5.328","article-title":"Evaluation of a procedure for the simultaneous quantification of 4-ketocyclophosphamide, cyclophosphamide, and Ifosfamide in human urine","volume":"48","author":"B\u2019Hymer","year":"2010","journal-title":"J Chromatogr Sci"},{"key":"10.3233\/WOR-172656_ref35","first-page":"368","article-title":"Biological monitoring of nurses exposed to doxorubicin and epirubicin by a validated liquid chromatography\/fluorescence detection method","volume":"54","author":"Pieri","year":"2010","journal-title":"Ann Occup Hyg"},{"key":"10.3233\/WOR-172656_ref36","first-page":"394","article-title":"Biological monitoring of occupational exposure to antineoplastic drugs in hospital settings","volume":"103","author":"Sabatini","year":"2012","journal-title":"Med Lav"},{"key":"10.3233\/WOR-172656_ref37","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.toxlet.2011.03.028","article-title":"Occupational exposure to antineoplastic drugs in four Italian health care settings","volume":"213","author":"Sottani","year":"2012","journal-title":"Toxicol Lett"},{"key":"10.3233\/WOR-172656_ref38","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/mutage\/gei048","article-title":"Investigating genetic damage in workers occupationally exposed to methotrexate using three genetic end-points","volume":"20","author":"Deng","year":"2005","journal-title":"Mutagenesis"},{"key":"10.3233\/WOR-172656_ref39","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/mutage\/16.1.71","article-title":"Application of the alkaline cometassay in human bio monitoring for genotoxicity","volume":"16","author":"Kopjar","year":"2001","journal-title":"Mutagenesis"},{"key":"10.3233\/WOR-172656_ref40","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/mutage\/gem032","article-title":"Genotoxicity assessment in oncology nurses handling anti-neoplastic drugs","volume":"22","author":"Rekhadevi","year":"2007","journal-title":"Mutagenesis"},{"key":"10.3233\/WOR-172656_ref41","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2354.2009.01150.x","article-title":"Occupational health and safety of personnel handling chemotherapeutic agents in Greek hospitals","volume":"20","author":"Constantinidis","year":"2011","journal-title":"Eur J Cancer Care"},{"key":"10.3233\/WOR-172656_ref42","first-page":"164","article-title":"Knowledge, attitude and safe behavior of nurses handling cytotoxic anticancer drugs in Ege University Hospital","volume":"5","author":"Turk","year":"2004","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.3233\/WOR-172656_ref43","doi-asserted-by":"crossref","first-page":"480","DOI":"10.2105\/AJPH.80.4.480","article-title":"Comparison of antineoplastic drug handling policies of hospitals with OSHA guidelines","volume":"80","author":"Valanis","year":"1990","journal-title":"Am J Public Health"},{"key":"10.3233\/WOR-172656_ref44","first-page":"102","article-title":"How do nurses manage their occupational exposure to cytotoxic drugs? A descriptive survey in chemotherapy settings, Shiraz, Iran","volume":"4","author":"Momeni","year":"2013","journal-title":"Int J Occup Environ Med"},{"key":"10.3233\/WOR-172656_ref45","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/annhyg\/mev031","article-title":"Efficacy of Two Cleaning Solutions for the Decontamination of 10 Antineoplastic Agents in the Biosafety Cabinets of a Hospital Pharmacy","volume":"59","author":"Anastasi","year":"2015","journal-title":"Ann Occup Hyg"},{"key":"10.3233\/WOR-172656_ref46","first-page":"24","article-title":"Profile of nurses working in oncology departments in Turkey","volume":"34","author":"Karadag","year":"2004","journal-title":"Turk J Cancer"},{"key":"10.3233\/WOR-172656_ref48","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/1078155211401454","article-title":"The PhaSeal\u00ae system: Impact of its use on workplace contamination and duration of chemotherapy preparation","volume":"18","author":"Favier","year":"2012","journal-title":"J Oncol Pharm Pract"},{"key":"10.3233\/WOR-172656_ref49","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1093\/ajhp\/60.22.2314","article-title":"Using a closed-system protective device to reduce personnel exposure to antineoplastic agents","volume":"60","author":"Wick","year":"2003","journal-title":"Am J Health Syst Pharm"},{"key":"10.3233\/WOR-172656_ref50","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3747\/co.22.2151","article-title":"Safe handling of cytotoxics: Guideline recommendations","volume":"22","author":"Easty","year":"2015","journal-title":"Curr Oncol"},{"key":"10.3233\/WOR-172656_ref51","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1188\/09.CJON.433-439","article-title":"Safe handling of hazardous drugs: Are you protected?","volume":"13","author":"Nixon","year":"2009","journal-title":"Clin J Oncol Nurs"},{"key":"10.3233\/WOR-172656_ref52","unstructured":"OSHA Technical Manual. Controlling occupational exposure to hazardous drugs, 5th Ed., Section 6, Chapter 2, OSHA Publication; 1999."},{"key":"10.3233\/WOR-172656_ref53","first-page":"1033","article-title":"ASHP technical assistance bulletin on handling cytotoxic and hazardous drugs","volume":"47","author":"American Society of Hospital Pharmacists","year":"1990","journal-title":"Am J Hosp Pharm"},{"key":"10.3233\/WOR-172656_ref54","unstructured":"Alehashem M , Baniasadi S . Safe handling of antineoplastic drugs in the university hospitals: A descriptive survey study among oncology nurses. International Journal of Cancer Management In Press."},{"key":"10.3233\/WOR-172656_ref55","first-page":"491","article-title":"Risks to health professionals from hazardous drugs in Iran: A pilot study of understanding of healthcare team to occupational exposure to cytotoxics","volume":"13","author":"Shahrasbi","year":"2014","journal-title":"Excli J"},{"key":"10.3233\/WOR-172656_ref56","first-page":"7","article-title":"Evaluation of the status of nurses preparing and administering chemotherapy","volume":"6","author":"Kubilay","year":"1996","journal-title":"Turkish Oncology Nurses Association\u2019s Bulletin"},{"key":"10.3233\/WOR-172656_ref57","first-page":"40","article-title":"Investigation of information level of nurses on protection from harmful effects of chemotherapy","author":"D\u00fczenli","year":"2000","journal-title":"1st National Congress of Midwife and Nurses Abstract Book. Antalya"},{"key":"10.3233\/WOR-172656_ref58","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ejon.2008.02.001","article-title":"Exploring the work of nurses who administer chemotherapy","volume":"12","author":"Verity","year":"2008","journal-title":"Eur J Oncol Nurs"},{"key":"10.3233\/WOR-172656_ref59","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1188\/03.ONF.575-581","article-title":"Chemotherapy-handling practices of outpatient and office-based oncology nurses","volume":"30","author":"Martin","year":"2003","journal-title":"Oncol Nurs Forum"},{"key":"10.3233\/WOR-172656_ref60","first-page":"57","article-title":"Exposure of hospital pharmacists and nurses to antineoplastic agents","volume":"35","author":"McDevitt","year":"1993","journal-title":"J Occup Med"},{"key":"10.3233\/WOR-172656_ref61","first-page":"57","article-title":"Biological, cytogenetic and ambient monitoring of exposure to antineoplastic drugs","volume":"4","author":"Pethran","year":"1998","journal-title":"J Oncol Pharm Practice"},{"key":"10.3233\/WOR-172656_ref62","first-page":"16","article-title":"Detection of contamination with antineoplastic agents in a hospital pharmacy department","volume":"14","author":"Sessink","year":"1992","journal-title":"Pharm Weekbl Sci"},{"key":"10.3233\/WOR-172656_ref63","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF00381477","article-title":"Occupational exposure to antineoplastic agents at several departments in a hospital. Environmental contamination and excretion of cyclophosphamide and ifosfamide in urine of exposed workers","volume":"64","author":"Sessink","year":"1992","journal-title":"Int Arch Occup Environ Health"},{"key":"10.3233\/WOR-172656_ref64","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1080\/00039899709602893","article-title":"Exposure of pharmacy technicians to antineoplastic agents: Reevaluation after additional protective measures","volume":"52","author":"Sessink","year":"1997","journal-title":"Int Arch Occup Environ Health"},{"key":"10.3233\/WOR-172656_ref65","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1310\/hpj4904-355","article-title":"Hazardous drug residue on exterior vial surfaces: Evaluation of a commercial manufacturing process","volume":"49","author":"Power","year":"2014","journal-title":"Hosp Pharm"},{"key":"10.3233\/WOR-172656_ref66","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1177\/107815520100600403","article-title":"How to protect environment and employees against cytotoxic agents, the UZ Ghent experience","volume":"6","author":"Vandenbroucke","year":"2001","journal-title":"J Oncol Pharm Practice"},{"key":"10.3233\/WOR-172656_ref67","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0003-4878(00)00050-8","article-title":"Postulating a dermal pathway for exposure to antineoplastic drugs among hospital workers. Applying a conceptual model to the results of three workplace surveys","volume":"44","author":"Kromhout","year":"2000","journal-title":"Ann Occup Hyg"},{"key":"10.3233\/WOR-172656_ref68","first-page":"455","article-title":"Association of antineoplastic drug handling with acute adverse effects in pharmacy personnel","volume":"50","author":"Valanis","year":"1993","journal-title":"Am J Hosp Pharm"},{"key":"10.3233\/WOR-172656_ref69","first-page":"432","article-title":"Work practice and some adverse health effects in nurses handling antineoplastic drugs","volume":"94","author":"Krstev","year":"2003","journal-title":"Med Lav"}],"container-title":["Work"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/WOR-172656","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T05:33:28Z","timestamp":1777613608000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/WOR-172656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,3]]},"references-count":68,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/wor-172656","relation":{},"ISSN":["1051-9815","1875-9270"],"issn-type":[{"value":"1051-9815","type":"print"},{"value":"1875-9270","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,3]]}}}